Articles On Avita Medical (ASX:AVH)
Title | Source | Codes | Date |
---|---|---|---|
Last Orders: ASX teeters on the edge of 7,400
The ASX climbed briefly past 7,400 points in intra-day trade but ultimately closed just short of the milestone at 7,.368, which was 0.09 per cent higher than yesterday. However, the ASX Emerging Companies Index fell by over 1 per cent for t... |
Stockhead | AVH | 3 years ago |
ASX 200 today: What to expect ahead of Fed’s statement
Summary The ASX 200 traded higher in the opening trade even as the US shares ended lower overnight. By 10:30 AM (AEST), the benchmark was trading at 7,391.50, up 0.16%. The US investors awaited the Federal Reserve’s monetary policy st... |
Kalkine Media | AVH | 3 years ago |
Q4 upgrade: Why the AVITA (ASX:AVH) share price is soaring
The AVITA Medical Inc (ASX: AVH) share price is soaring today, up 9%, after upgrading its FY21 fourth quarter expectations. AVITA is a regenerative medicine company that is developing and commercialising a technology platform that enables p... |
Rask Media | AVH | 3 years ago |
Why the AVITA (ASX:AVH) share price is jumping 8% today
The AVITA Medical Inc (ASX: AVH) share price is on the move on Wednesday. At the time of writing, the regenerative medicine company’s shares are up 8% to $5.40. Why is the AVITA share price jumping? Investors have been buying the company’s... |
Motley Fool | AVH | 3 years ago |
Market highlights and 5 ASX small caps to watch on Wednesday
Wall Street nervous as Fed goes into a two-day policy meeting All major indices in the US fell on Tuesday, ahead of a key policy announcement from the US central bank this Thursday (US time). The Dow Jones fell by 0.27%, S&P 500 by 0.20... |
Stockhead | AVH | 3 years ago |
Argenica Therapeutics (ASX:AGN) shares surge ~30% on Day 1 on the ASX
Summary Neuroprotective drug developer Argenica Therapeutics commenced trading on the ASX after a well-supported AU$7 million capital raising. The Company disclosed that the ASX listing would allow it to develop its novel neuroprotecti... |
Kalkine Media | AVH | 3 years ago |
Last Orders: ASX a whisker from closing the week at all time high
The ASX ended the week on a high note, finishing up 0.13 per cent with most sectors in positive territory. The index touched a record high of 7,334 today but failed to keep the momentum and eventually closed at 7,312. For the week, the inde... |
Stockhead | AVH | 3 years ago |
Avita Medical's burns treatment rejuvenated by FDA use extension
Avita Medical Inc. (ASX: AVH) has received a big shot in the arm following an extension of US Food and Drug Administration approvals for the company's treatment of acute burns wounds. The medtech company, which is also listed in the US (N... |
businessnewsaustralia.com | AVH | 3 years ago |
Why Afterpay, Altium, AVITA, & Domino’s shares are pushing higher
The S&P/ASX 200 Index (ASX: XJO) is fighting hard to finish the week on a positive note. In afternoon trade, the benchmark index is up 0.2% to 7,315.8 points. Four ASX shares that are climbing more than most today are listed below. Her... |
Motley Fool | AVH | 3 years ago |
Why the Avita Medical (ASX:AVH) share price is soaring 14%
The Avita Medical Inc (ASX: AVH) share price is flying high on Friday. At the time of writing, shares in the medical technology business are swapping hands for $5.11 – up 13.56%. This comes after the company announced it had received appro... |
Motley Fool | AVH | 3 years ago |
FDA gives green light to Avita’s ‘spray-on’ burns treatment for children, shares gain
Burns treatment company Avita Medical (ASX:AVH) rose this morning after gaining further regulatory approval from the FDA. The company has a rapid cell harvesting device called RECELL which works as a ‘spray-on’ and allows patients to be tre... |
Stockhead | AVH | 3 years ago |
Why the AVITA (ASX:AVH) share price is booming
The AVITA Medical Inc (ASX: AVH) share price is up more than 14% after getting some positive news from the US FDA. AVITA is a regenerative medicine business that is developing and commercialising a “technology platform” that enables point-o... |
Rask Media | AVH | 3 years ago |
10 at 10: These ASX stocks are performing well this morning
Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov... |
Stockhead | AVH | 3 years ago |
Market highlights and 5 ASX small caps to watch on Friday
Wall Street rises despite strong US inflation data All major indices in the US closed higher on Thursday, even as US May consumer prices data rose more than forecast. Headline US CPI rose by 5% on a year-on-year basis for May. Investors are... |
Stockhead | AVH | 3 years ago |
ASX 200 rebounds, Treasury rises, Xero falls
The S&P/ASX 200 Index (ASX: XJO) rose by 0.45% today to 7,014 points. Here are some of the highlights from the ASX: AVITA Medical Inc (ASX: AVH) The AVITA share price went around 3% today after the healthcare business gave its quart... |
Motley Fool | AVH | 3 years ago |
Avita (ASX:AVH) share price pushes higher on Q3 update
This morning, medical device developer Avita Medical Inc (ASX: AVH) released its Q3 FY21 results to the market. Avita’s shares are up 2.9% at the time of writing. While many ASX companies saw a V-shaped recovery coming out of COVID-19, Avit... |
Rask Media | AVH | 3 years ago |
Why the AVITA (ASX:AVH) share price is charging higher today
The AVITA Medical Inc (ASX: AVH) share price is on the move on Friday morning. At the time of writing, the regenerative medicine company’s shares are up 4% to $5.35. Why is the AVITA share price charging higher? Investors have been buying... |
Motley Fool | AVH | 3 years ago |
Market highlights and 5 ASX small caps to watch on Friday
Wall Street climbs on better US jobs market All major indices in the US rebounded on Thursday, after US jobless claims fell by 34,000 to a 14-month low of 473,000 in the past week, beating estimates. Dow Jones climbed 1.29%, S&P 500 ros... |
Stockhead | AVH | 3 years ago |
Dr Boreham’s Crucible: Why is Pharmaxis’ valuation so ‘pitiful’? Karst Peak doesn’t know either
Inflammatory diseases company Pharmaxis (ASX:PSX) this month welcomed a familiar biotech name to the register: Karst Peak Capital. The Hong Kong and Sydney based ‘contrarian’ fund manager is also a major holder in Neuren and Cyclopharm, and... |
Stockhead | AVH | 3 years ago |
ScoPo’s powerplays: Antisense ‘looks like it wants to run harder’
Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. Themes of the week The ASX he... |
Stockhead | AVH | 3 years ago |
Last Orders: ASX back in the green as ‘risk on’ sentiment returns
Risk on sentiment has returned to the ASX. The ASX finished 0.78 per cent higher at 6,791 points although it peaked at 6,861 earlier today, which was nearly 2 per cent higher than the day before. The ASX Emerging Companies Index however los... |
Stockhead | AVH | 3 years ago |
3 Healthcare stocks to keep the portfolio’s health in check
Source: janews, Shutterstock Summary Healthcare sector has started to do well as higher number of patients are getting access to hospitals amid eased restrictions. Fisher and Paykel reported a growth of 73 per cent in operating revenu... |
Kalkine Media | AVH | 3 years ago |
ASX medical shares report promising half-year results
ASX medical shares reported some positive results in the most recent reporting round. The medical sector is a popular choice for both growth and income investors. More mature shares such as Cochlear Limited (ASX: COH) and Fisher & Pay... |
Motley Fool | AVH | 3 years ago |
These are the 10 most shorted shares on the ASX
At the start of each week I like to look at ASIC’s short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels c... |
Motley Fool | AVH | 3 years ago |
These are the 10 most shorted shares on the ASX
At the start of each week I like to look at ASIC’s short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels c... |
Motley Fool | AVH | 3 years ago |
Australian Broker Call *Extra* Edition – Feb 24, 2021
An additional news report on the recommendation, valuation, forecast and opinion changes for ASX-listed equities. In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Au... |
FNArena | AVH | 3 years ago |
These are the 10 most shorted shares on the ASX
At the start of each week I like to look at ASIC’s short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels c... |
Motley Fool | AVH | 3 years ago |
Why the Avita Medical (ASX:AVH) share price is slipping lower today
The Avita Medical Inc (ASX: AVH) share price has stayed in the red today since the company announced its half-year results this morning. At the time of writing, shares in the regenerative medicine company are down 2.66% at a price of $6.23... |
Motley Fool | AVH | 3 years ago |
How do Avita Medical (ASX:AVH) shares stack up against Polynovo and Aroa Biosurgery?
ASX mid-cap healthcare company Avita Medical Inc (ASX: AVH) released its second-quarter FY21 results to the market last week. Despite recording positive revenue numbers, the Avita share price has continued to slide lower over the last five... |
Motley Fool | AVH | 3 years ago |
These are the 10 most shorted shares on the ASX
At the start of each week I like to look at ASIC’s short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels c... |
Motley Fool | AVH | 3 years ago |
Why AVITA Medical’s (ASX:AVH) shares are 12% down today?
Summary Regenerative medicine company AVITA Medical’s US RECELL® revenue increased by 62% in Q2 FY21. AVITA Medical is unable to forecast any financial guidance amid COVID-19 uncertainty. Dual-listed company disclosed that it has cont... |
Kalkine Media | AVH | 3 years ago |
Will the Avita (ASX:AVH) Q2 result regenerate its share price?
Today, Avita Medical Inc (ASX: AVH) reported positive numbers for its second-quarter (Q2) of FY21 and the share price sank 11%. Is Avita on its way to restoring its share price to pre-COVID levels? Avita is a regenerative medicine business... |
Rask Media | AVH | 3 years ago |
Why AVITA, Baby Bunting, Kathmandu, & Webjet shares are sinking
In afternoon trade the S&P/ASX 200 Index (ASX: XJO) is on course to end the week on a subdued note. At the time of writing, the benchmark index is down 0.3% to 6,828.7 points. Four ASX shares that are falling more than most today are l... |
Motley Fool | AVH | 3 years ago |
Australia…One Hour In…ASX down 12 points
ShareCafeAustralia…One Hour In…ASX down 12 points ASX200 down 12 points (0.2%) to 6837 Avita Medical (-5.8%); reported 2Q loss and gave no guidance due to pandemic. Baby Bunting (-3%); 1H profit $7.5m, up 55% yoy but below most broker es... |
ShareCafe | AVH | 3 years ago |
ASX 200 today: Why Australian market opened lower today
Summary The ASX 200 opened marginally lower on Friday, down 7.30 points or 0.11 per cent to 6842.80, following yet another day of choppy trading at Wall Street. While the ASX 200 Information Technology was trading down 2.126 per cent,... |
Kalkine Media | AVH | 3 years ago |
The AVITA Medical (ASX: AVH) share price plummets almost 6% in early trade
The AVITA Medical Inc (ASX: AVH) share price has plunged in opening trade today after the company released its second-quarter results for the fiscal year 2021. At the time of writing, the AVITA share price is trading at 5.85% lower at $6.... |
Motley Fool | AVH | 3 years ago |
What are the ASX stocks vulnerable to a ‘short squeeze’?
Could the ASX become subject to the same trading shenanigans in the US which put a rocket up the share price of struggling video outlet operator GameStop and then the silver market. It’s certainly food for short … er, thought. This month sh... |
SmallCaps | AVH | 3 years ago |
Short & Caught: Here are the 20 most shorted ASX stocks right now
In Short & Caught, Stockhead recaps the 20 most shorted ASX stocks. How does shorting work? Shorting works by selling stocks you do not actually own in the hope of buying them back at a lower price. Investors are in effect betting the... |
Stockhead | AVH | 3 years ago |
Here are the 10 most shorted shares on the ASX
At the start of each week I like to look at ASIC’s short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels c... |
Motley Fool | AVH | 3 years ago |
January in Review: Rotation, Volatility, Net Flat
During January the ASX200 ended the month virtually where it started with consumer discretionary and banks the standout sectors -The ASX made gains of 0.3% in January-Value outperformed growth-Commodity prices were a key area of strength-FY... |
FNArena | AVH | 3 years ago |
GameStop effect: 3 more shorted ASX shares that could skyrocket
So we’ve now seen the GameStop Corp (NYSE: GME) share price multiply 2300% in just 2 weeks after a short squeeze attack from Reddit-driven retail investors. The bubble has now deflated somewhat since its mad highs. But last week there was... |
Motley Fool | AVH | 3 years ago |
ASX reporting season calendar – February 2021
Hold onto your hats – it’s ASX reporting season! The team at Rask Media have put together a list of when companies are expected to release their financial results this February 2021. Make sure to bookmark this page because we’ll be adding l... |
Rask Media | AVH | 3 years ago |
Here are the 10 most shorted shares on the ASX
At the start of each week I like to look at ASIC’s short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels c... |
Motley Fool | AVH | 3 years ago |
Here are the 10 most shorted shares on the ASX
At the start of each week I like to look at ASIC’s short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels c... |
Motley Fool | AVH | 3 years ago |
Most shorted stocks and revived Aussie consumer
Summary Some consumer discretionary stocks have had a phenomenal run after the market crash in March 2020, but not all have recovered to their peaks. As earnings season is approaching, it is the time when expectations, which is priced... |
Kalkine Media | AVH | 3 years ago |
Here are the 10 most shorted shares on the ASX
At the start of each week I like to look at ASIC’s short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels c... |
Motley Fool | AVH | 3 years ago |
S&P/ASX 200 morning report – ALU, ARB & PNV shares in focus
The S&P/ASX 200 (ASX: XJO) is expected to take a slight backwards step when the market opens on Wednesday according to the latest SPI futures. Here’s what ASX investors need to know. ASX 200 slide continues, Altium flags weakness The AS... |
Rask Media | AVH | 3 years ago |
These 3 ASX shares all posted massive gains today
It was an unimpressive day for the ASX today with the All Ordinaries Index (ASX: XAO) sagging 0.2% at the market’s close. Regardless of this lacklustre result, these three ASX shares each had a ripper session, with their share prices all... |
Motley Fool | AVH | 3 years ago |
Here’s why the AVITA (ASX:AVH) share price is going bananas
The AVITA Medical Inc (ASX: AVH) share price is up more than 15% after giving a FY20 second quarter update. Avita is a regenerative medicine company that is developing and commercialising a technology platform that enables point of care aut... |
Rask Media | AVH | 3 years ago |
What is Driving AVITA Medical’s (ASX:AVH) Share Price?
Summary AVITA Medical highlighted its anticipated revenue and other commercial metrics for the second quarter of 2021. US-based RECELL revenue increased by 62% and total global revenue by 57% over the same quarter in the prior year. D... |
Kalkine Media | AVH | 3 years ago |